Cargando…
Citrus Flavone Tangeretin Inhibits CRPC Cell Proliferation by Regulating Cx26, AKT, and AR Signaling
Prostate cancer (PCa) progression depends on the action of androgen receptors (AR). Therefore, preventing ligand-mediated activation of AR is the first-line treatment strategy for metastatic PCa. Androgen deprivation therapy (ADT) can inhibit ligand binding to AR and alleviate PCa progression initia...
Autores principales: | Zhang, Ningfang, Wu, Wenqi, Huang, Yapeng, An, Lingyue, He, Zhichan, Chang, Zhenglin, He, Zhaohui, Lai, Yongchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803427/ https://www.ncbi.nlm.nih.gov/pubmed/35111229 http://dx.doi.org/10.1155/2022/6422500 |
Ejemplares similares
-
Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors
por: Lai, Yongchang, et al.
Publicado: (2023) -
Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes.
por: Hirano, T., et al.
Publicado: (1995) -
Microencapsulation of Tangeretin in a Citrus Pectin Mixture Matrix
por: Sun, Xiuxiu, et al.
Publicado: (2020) -
Therapeutic Implications of a Polymethoxylated Flavone, Tangeretin, in the Management of Cancer via Modulation of Different Molecular Pathways
por: Arafa, El-Shaimaa A., et al.
Publicado: (2021) -
Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
por: White, Ralph E., et al.
Publicado: (2023)